North America Heparin Market Size & Outlook, 2023-2030
North America heparin market, 2018-2030 (US$M)
Related Markets
North America heparin market highlights
- The North America heparin market generated a revenue of USD 2,926.0 million in 2023.
- The market is expected to grow at a CAGR of 1.8% from 2024 to 2030.
- In terms of segment, porcine was the largest revenue generating source in 2023.
- Bovine is the most lucrative source segment registering the fastest growth during the forecast period.
- Country-wise, Canada is expected to register the highest CAGR from 2024 to 2030.
North America data book summary
| Market revenue in 2023 | USD 2,926.0 million |
| Market revenue in 2030 | USD 3,324.1 million |
| Growth rate | 1.8% (CAGR from 2023 to 2030) |
| Largest segment | Porcine |
| Fastest growing segment | Bovine |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Porcine, Bovine |
| Key market players worldwide | Pfizer Inc, Sanofi SA, Aspen Pharmacare Holdings Ltd, Fresenius SE & Co KGaA, Novartis AG ADR, GSK PLC ADR, Dr. Reddy’s Laboratories, LEO Pharma, B. Braun Medical |
Other key industry trends
- In terms of revenue, North America region accounted for 39.6% of the global heparin market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 2,436.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Heparin Market Scope
Heparin Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America heparin market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to heparin market will help companies and investors design strategic landscapes.
Porcine was the largest segment with a revenue share of 89.76% in 2023. Horizon Databook has segmented the North America heparin market based on porcine, bovine covering the revenue growth of each sub-segment from 2018 to 2030.
North America held the largest share of the heparin market in 2019. Increasing sports injuries in this region is one of the major factors driving its overall market. According to a study published in Stanford Children's Health, around 3.5 million recorded injuries each year have been caused by some form of sports activities.
In addition, it was stated that many of the injuries are observed in children in this region. As per the Harvard School of Public Health, by 2030, roughly half of the U.S. population will be obese. As per Obesity Canada in 2019, the obesity rate in Canada is projected to rise.
Related health issues, such as blood clots and stroke, are also expected to increase in prevalence, further contributing to market growth. The Heparin supply chain has been disrupted by COVID-19, as China has been the leading supplier of heparin API globally.
Reasons to subscribe to North America heparin market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America heparin market databook
-
Our clientele includes a mix of heparin market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America heparin market , including forecasts for subscribers. This continent databook contains high-level insights into North America heparin market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America heparin market size, by country, 2018-2030 (US$M)
North America Heparin Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
